In mouse models of AD, PKM2-specific deletion in microglia lowered Aβ burden and enhanced spatial learning and memory, indicating that disrupting the glycolysis/H4K12la/PKM2 positive feedback loop may offer useful therapeutic approaches for AD [54]. Here, PKM is linked to Alzheimer disease.